|
Originally published In Press as doi:10.1074/jbc.M101148200 on April 19, 2001
J. Biol. Chem., Vol. 276, Issue 28, 25775-25782, July 13, 2001
Tumoricidal Activity of Endothelial Cells
INHIBITION OF ENDOTHELIAL NITRIC OXIDE PRODUCTION
ABROGATES TUMOR CYTOTOXICITY INDUCED BY HEPATIC SINUSOIDAL ENDOTHELIUM
IN RESPONSE TO B16 MELANOMA ADHESION IN VITRO*
Julian
Carretero §,
Elena
Obrador ¶,
Juan M.
Esteve ,
Angel
Ortega ,
José A.
Pellicer ,
Francisco Vera
Sempere**, and
José M.
Estrela 
From the Departamento de Fisiología,
Universidad de Valencia, and the ** Servicio de Anatomía
Patológica, Hospital Universitario La
Fe, Valencia, Spain
Received for publication, February 6, 2001, and in revised form, April 19, 2001
 |
ABSTRACT |
The mechanism of NO- and
H2O2-induced tumor cytotoxicity was
examined during B16 melanoma (B16M) adhesion to the hepatic sinusoidal endothelium (HSE) in vitro. We used endothelial
nitric-oxide synthetase gene disruption and
NG-nitro-L-arginine methyl
ester-induced inhibition of nitric-oxide synthetase activity to study
the effect of HSE-derived NO on B16M cell viability. Extracellular
H2O2 was removed by exogenous catalase. H2O2 was not cytotoxic in the absence of NO.
However, NO-induced tumor cytotoxicity was increased by
H2O2 due to the formation of potent oxidants,
likely ·OH and OONO radicals, via a trace
metal-dependent process. B16M cells cultured to low density
(LD cells), with high GSH content, were more resistant to NO and
H2O2 than B16M cells cultured to high density
(HD cells; with ~25% of the GSH content found in LD cells). Resistance of LD cells decreased using buthionine sulfoximine, a
specific GSH synthesis inhibitor, whereas resistance increased in HD
cells using GSH ester, which delivers free intracellular GSH. Because
NO and H2O2 were particularly cytotoxic in HD
cells, we investigated the enzyme activities that degrade
H2O2. NO and H2O2
caused an ~75% (LD cells) and a 60% (HD cells) decrease in catalase
activity without affecting the GSH peroxidase/GSH reductase system.
Therefore, B16M resistance to the HSE-induced cytotoxicity appears
highly dependent on GSH and GSH peroxidase, which are both required to
eliminate H2O2. In agreement with this fact, ebselen, a GSH peroxidase mimic, abrogated the increase in NO toxicity
induced by H2O2.
 |
INTRODUCTION |
Interaction of cancer and endothelial cells in capillary beds is a
critical step in the initiation of metastasis (1). Early studies on the
organ distribution of B16 melanoma
(B16M)1 cells showed that
<0.1% of circulating cells survive and may promote secondary
metastatic growth (2). The liver is a common site for metastasis
development, and it has been shown that, under experimental conditions,
a high percentage of circulating cancer cells are mechanically trapped
in the liver microvasculature (3). Interaction of metastatic cancer
cells with the hepatic sinusoidal endothelium (HSE) and Kupffer cells
activates local release of pro-inflammatory cytokines, which can
promote cancer cell adhesion, invasion, and proliferation (4-6).
Indeed, interleukin-1 (IL-1) and tumor necrosis factor- (TNF- )
induce binding of very late antigen-4-expressing mouse B16M cells by
up-regulating vascular adhesion molecule-1 on endothelial cells (6, 7)
and thereby facilitate metastatic growth (8, 9). In addition,
endothelial cells also release harmful reactive oxygen species in
response to endotoxins and cytokines or in response to cancer cell
contact (10-12). However, at low micromolar levels, these reactive
species appear to act as intra- and intercellular messengers capable of promoting growth responses (13). In fact, vascular adhesion molecule-1
gene transcription and expression in vascular endothelial cells are
coupled to an oxidative stress-dependent mechanism (14). Therefore, a balanced process between pro- and anti-metastatic reactive
oxygen species effects may underlie the interaction of metastatic cells
with the vascular endothelium.
According to this idea, it has been shown that
IL-1-dependent HSE production of
H2O2 contributes to melanoma cell adhesion enhancement, which would compensate for its direct cytotoxic effects on
adherent, vulnerable melanoma cells and lead to the metastatic progression of H2O2-resistant melanoma cells
(6). The involvement of H2O2 in cancer cell
cytotoxicity is supported by experiments in which the hepatic
metastasizing ability of B16M cells, following intrasplenic inoculation
of IL-1-treated mice, was reduced by administration of exogenous
catalase or enhanced by exogenous superoxide dismutase (6).
Nevertheless, to date, data reported on H2O2
released by the vascular endothelium during the process of cancer cell
adhesion regard to relative values. Quantitative determination
of H2O2 levels is necessary to assess whether
H2O2 induces tumor cytotoxicity by itself or
requires some additional factor(s).
Elegant studies by Fidler and co-workers (15) showed that NO, the
formation of which is catalyzed by constitutive NO synthetase or
inducible NO synthetases expressed in many cells, promotes lysis of
tumor cells by cytokine-activated endothelial cells. Interestingly, an
inverse correlation between expression of inducible NO synthase
activity and production of metastasis in murine melanoma cells was
found (16). In addition, recent results have identified the existence
of a natural defense mechanism against cancer metastasis whereby the
arrest of tumor cells in the liver induces endogenous NO release,
leading to sinusoidal tumor cell killing and reduced hepatic metastasis
formation (17). Although the biochemical mechanisms by which NO elicits
its cytotoxic action are not well understood, it has been proposed
that, for example, NO inactivates iron-containing prosthetic groups, a
mechanism that leads to inhibition of the mitochondrial respiratory
chain and DNA synthesis (18), and that NO reacts very rapidly with
O 2, which results in formation of the highly oxidant
peroxynitrite (19). Moreover previous reports have shown cooperative
cytotoxic action of nitric oxide and H2O2 in,
for example, Escherichia coli (20) and Fu5 rat hepatoma
cells (21). Therefore, it is plausible that endothelial NO and
H2O2 or their derived reactive species may have
synergistic cytotoxic effects on cancer cells. Interestingly, reactive
nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion have been recently involved in the killing of weakly (but not highly)
metastatic colorectal cancer cells (22). In addition, we have shown
that GSH, which is involved in cell defense against nitrosative and
oxidative stress (23), protects circulating B16M cells against
HSE-induced cytotoxicity (24). In the present work, we have used
endothelial nitric-oxide synthetase (eNOS) gene disruption and
NG-nitro-L-arginine methyl ester
(L-NAME)-induced inhibition of NO production to study the
role of endothelium-derived NO in the killing of B16M cells. In these
studies, we have compared B16M cells cultured to low (LD) and high (HD)
densities, which have different GSH contents and different metastatic
activities (25). Our results show that H2O2
released by the HSE was not cytotoxic; however, NO was particularly
tumoricidal in the presence of the peroxide. A high percentage of tumor
cells with high GSH content survived the combined nitrosative and
oxidative attacks and may represent the main task force in metastatic invasion.
 |
EXPERIMENTAL PROCEDURES |
Culture of B16M Cells--
B16M cells derived from B16-F10
subline cells were cultured (24) in Dulbecco's modified Eagle's
medium (Life Technologies, Inc.), pH 7.4, supplemented with 10% fetal
calf serum (Life Technologies, Inc.), 10 mM HEPES, 40 mM NaHCO3, 100 units/ml penicillin, and 100 µg/ml streptomycin.
Isolation, Identification, and Culture of the Hepatic Sinusoidal
Endothelium--
Male C57BL/6J mice (10-12 weeks old) were from the
Institut Français pour la Fiévre Aphtose Credo
(L'Arbreole, France). All animals received care according to the
criteria outlined by the National Institutes of Health (Rockville, MD).
The HSE was separated and identified as previously described (26).
Tissue digestion was carried out by sequential perfusion of type E
Pronase and collagenase A (Roche Molecular Biochemicals, Mannheim,
Germany) plus Pronase solutions. The liver was then minced and stirred in another solution containing Pronase, collagenase, and DNase (type I
deoxyribonuclease, Sigma). Sinusoidal cells were separated in a 17.5%
(w/v) metrizamide gradient. Cultures of the HSE were established and
maintained in pyrogen-free Dulbecco's modified Eagle's medium
supplemented as described above for the B16M cells. Differential
adhesion of endothelial cells to the collagen matrix and washing allow
complete elimination of other sinusoidal cell types (Kupffer, stellate,
and lymphocytes) from the culture flasks.
B16 Melanoma-Endothelial Cell Adhesion Assay--
This assay was
based on a previously published methodology (6). Briefly, B16M cells
were loaded with 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM; Molecular Probes, Inc., Eugene OR)
(106 cells were incubated in 1 ml of HEPES-buffered
Dulbecco's modified Eagle's medium containing 50 µg of BCECF-AM and
5 µl of Me2SO for 20 min at 37 °C). After washing,
BCECF-AM-containing cells were resuspended in HEPES-buffered
Dulbecco's modified Eagle's medium without phenol red at a
concentration of 2.5 × 106 cells/ml and added (0.2 ml/well) to endothelial cells (plated 24 h before) and also to
plastic- or collagen-precoated control wells. The plates were then
incubated at 37 °C; and 20 min later, the wells were washed three
times with fresh medium and read for fluorescence. This was measured
using a Fluoroskan Ascent FL (Labsystems, Manchester, United
Kingdom). The number of adhering tumor cells was quantified by
arbitrary fluorescence units based on the percentage of the initial
number of B16M cells added to the HSE culture.
In Vitro Cytotoxicity Assays--
Damage to B16M cells during
their in vitro adhesion to the HSE was measured, as
previously described (24), using tumor cells loaded with calcein-AM
(Molecular Probes, Inc.). Integrity of B16M cells cultured alone was
assessed by trypan blue exclusion and by measuring lactate
dehydrogenase activity (27) released to the extracellular medium (24).
Other reagents used in experiments of tumor cytotoxicity were from
Sigma (L-NAME, catalase, and superoxide dismutase).
Cytokines--
Recombinant murine TNF- (2 × 107 units/mg of protein), recombinant murine IL-1 (20 µg/mg of protein), and recombinant murine interferon- (IFN- ;
105 units/mg of protein) were obtained from Sigma. Stock
solutions (5 × 105 units/ml TNF- , 100 ng/ml
IL-1 , and 25 × 104 units/ml IFN- ) were diluted
in sterile physiological saline solution (0.9% NaCl), adjusted to pH
7.0, and stored at 4 °C.
Measurement of H2O2, Nitrite, and
Nitrate--
The assay of H2O2 production was
based on the H2O2-dependent
oxidation of homovanillic acid (4-hydroxy-3-methoxyphenylacetic acid)
to a highly fluorescent dimer (2,2'-dihydroxydiphenyl-5,5'-diacetic acid), which is mediated by horseradish peroxidase (28). For this
purpose, cells were cultured in the presence of 100 µM
homovanillic acid and 1 unit/ml horseradish peroxidase. A linear
relationship between fluorescence ( ex = 312 nm and
em = 420 nm) and amount of H2O2
was found in the range of 0.1-12 nmol/2-ml assay.
Nitrite and nitrate determinations were performed using the methodology
of Braman and Hendrix (29). Briefly, measurement of
NO levels was made by monitoring NO
evolution via chemiluminescence detection from a measured sample placed
into a refluxing solution of iodide/acetic acid (which will reduce only
NO , but not
NO , to NO). Total
NO plus
NO (NOx) determinations were
made by monitoring NO evolution from a measured sample placed into a
boiling VCl3/HCl solution (which will reduce both
NO and
NO to NO). The determination of
NO levels was made by subtracting the
NO value from the NOx value.
Quantitation was accomplished using a standard curve made up of known
amounts of NO and
NO .
Measurement of GSH, GSSG, and S-Nitrosothiols--
For GSH
determination, cells were treated at 4 °C with ice-cold perchloric
acid (2%). Samples were centrifuged at 15,000 × g for
5 min at 4 °C and GSH was measured in the supernatants using the GSH
S-transferase reaction as previously described (30).
For GSSG analysis, cells were treated at 4 °C with ice-cold
perchloric acid (12%) containing 40 mM
N-ethylmaleimide (Sigma) and 2 mM
bathophenanthrolinedisulfonic acid (Sigma). Samples were centrifuged at
15,000 × g for 5 min at 4 °C and the acidic
supernatants were derivatized and analyzed by high performance liquid
chromatography as previously reported (31).
The acid-soluble fractions (200 µl) obtained for GSH determination
(see above) were added to 25 µl of 2.0% ammonium sulfamate. To the
mixtures were added 200 µl of 0.5 N HCl containing 0.25% HgCl2 and 5% sulfanilamide. Then, 250 µl of a 0.5 N HCl solution containing 0.25%
N-(1-naphthyl)ethylenediamide dihydrochloride were added to the mixtures. After incubation for 30 min at 25 °C,
the amount of S-nitrosothiols (RSNO) was determined
spectrophotometrically at 550 nm using S-nitrosoglutathione
(GSNO) as a standard (32). Fresh GSNO solution was obtained, before
each experiment, by incubating equimolar GSH and sodium nitrite in
acidified water at 0 °C as previously described (33). GSNO
concentration was determined spectrophotometrically at 335 nm ( = 992 dm3 × mol 1 × cm 1) and at 545 nm ( = 15.9 dm3 × mol 1 × cm 1). No significant decomposition of GSNO
occurred during the assay procedures.
Preparation of GSH Ester--
GSH monoisopropyl(glycyl) ester
was obtained as previously described (34).
Preparation of NO Solution--
Thionitrobenzoic acid was used
to characterize the stability of a NO solution obtained by bubbling a
50 mM HEPES-NaOH buffer (pH 7.4) with NO gas as previously
described (35). Levels of NO were measured as previously reported (36)
using a Sievers NOA 280A chemiluminescence analyzer. Briefly, samples
(100 µl) were injected into a nitrogen purge vessel containing a 1%
solution of sodium iodide in glacial acetic acid to liberate gaseous NO from dissolved NO and nitrite. The sample gas was then exposed to ozone
to form activated nitrogen dioxide (NO2*), which
luminescences in the red and far-red spectrum and is detected by
a red-sensitive photomultiplier tube. For calculations, we used a
calibration curve obtained by measuring a series of sodium nitrite
standards. The saturated NO solution (2 mM) was stored at
4 °C and used for experiments within 15 min. During this time
period, NO concentration in stock solutions remained unchanged.
Preparation of Peroxynitrite Solution--
Peroxynitrite was
prepared from amyl nitrite and H2O2 following
the methodology described by Uppu and Pryor (37). Amyl nitrite (20 ml)
was added to 80 ml of 2 M H2O2, 2 M NaOH, and 2 mM DTPA, and the solution was
stirred for 2 h at 4 °C. The lower aqueous layer was removed
and washed three times with ice-cold hexane. Residual
H2O2 was removed by gradually adding 10 g
of manganese dioxide to the OONO solution while it was
being stirred on ice for 1 h. The solution was filtered and passed
through a 10 × 1-cm MnO2 column equilibrated with 0.1 M NaOH to remove traces of
H2O2. The OONO was diluted with
0.1 N NaOH to ~50 mM immediately before use.
The concentration of OONO was measured
spectrophotometrically (extinction coefficient of 1670 M 1 × cm 1 at 302 nm). Nitrite contamination of the
OONO solution was ~20% of the OONO
concentration (less than that reported in the original method (37)).
Addition of catalase to decomposed peroxynitrite at pH 7.0 resulted in
no oxygen evolution (measured at 37 °C with a Clark-type electrode),
which implies no H2O2 contamination in the solution.
Measurement of Antioxidant Enzyme Activities--
B16M cells
were detached (see above) and washed twice at 4 °C in
Krebs-Henseleit bicarbonate medium (pH 7.4) without Ca2+ or
Mg2+ added and containing 0.5 mM EGTA and then
resuspended in ice-cold lysis buffer (0.1 M phosphate
buffer (pH 7.2) containing 1 mM phenylmethylsulfonyl
fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin, and 5 µg/ml
pepstatin A (Sigma)) at a density of ~15 × 106
cells/ml. Cells were disrupted by sonication (Braun Labsonic; 50%
output, three times for 10-s each), and the suspension was centrifuged
at 12,000 × g for 15 min at 4 °C. GSH reductase
activity (30), GSH peroxidase (selenium-dependent) activity
(using H2O2 as a substrate) (38), superoxide
dismutase activity (39), and catalase activity (40) were measured in
the supernatants as described previously.
eNOS-deficient Mice--
Generation of eNOS-deficient mice was
carried out as previously described (41). We interbred heterozygous
(+/ ) eNOS-deficient mice to generate eNOS+/+ and
eNOS / mice. We used eNOS+/+ and
wild-type C57BL/6J mice as controls. Genotyping of the animals was
performed by Southern blotting DNA from tail biopsies. The identification of eNOS+/+ and
eNOS / mice was as previously described
(41). Briefly, 20-µg samples were digested with BamHI,
separated on 1.0% agarose gels, and then transferred to
nylon-supported nitrocellulose. The blots were hybridized using a
random primer-labeled 1.4-kilobase pair eNOS cDNA probe
(41). A 5.3-kilobase pair fragment was diagnostic of the endogenous
eNOS locus, and a 6.4-kilobase pair fragment was diagnostic of the
targeted allele.
Immunohistochemical Localization of eNOS--
Livers were
rapidly removed and embedded in Miles Tissue-Tek OCT compound
(Sciscope, Iowa City, IA) for preparing 5-µm frozen sections.
Sections were fixed with acetone ( 20 °C at the start) for 10 min
at 4 °C and washed twice with PBS containing 0.1 g of bovine
serum albumin/100 ml at room temperature. Sections were then incubated
with 0.25% H2O2 in methanol for 30 min at room temperature to block endogenous peroxidase activity and washed again
with PBS containing 0.1% bovine serum albumin. Nonspecific antibody
binding was blocked by incubation for 3 h with PBS containing 5%
bovine serum albumin. Sections were then washed twice with PBS
containing 0.1% bovine serum albumin and incubated for 1 h with a
mouse anti-eNOS antibody (diluted 1:100; kit 482731, Calbiochem). After
sections were washed for 15 min with PBS, biotinylated goat anti-mouse
immunoglobulin G (kit 4002, Vector Labs, Inc., Burlingame, CA) was
applied for 30 min. Sections were washed and developed with the
Vectastain ABC system (Vector Labs, Inc.) using tetrahydrochloride. Sections were counterstained with hematoxylin and examined by light
microscopy for staining of eNOS (dark-purple color), which was positive
in wild-type and eNOS+/+ mice and completely negative in
eNOS / mice (data not shown).
Statistical Analyses--
Data were analyzed by Student's
t test.
 |
RESULTS |
In Vitro NO and H2O2 Generation by
Cytokine-stimulated HSE--
The incubation of endothelial cells with
cytokines can induce the production of different mediators, among which
are NO (15) and H2O2 (12). Rolling and early
adhesion of B16M cells to the HSE, release of
H2O2 by the HSE, and late adhesion of surviving melanoma cells are sequential steps during B16M cell attachment to the
HSE that occur in a short period (3-6 h) (6). In the first set of
experiments, to determine the rates of NO and
H2O2 generated by the HSE, freshly isolated
sinusoidal cells were treated with different concentrations of TNF- ,
IL-1 , and/or IFN- (Table I). All
these cytokines have been shown to be capable of activating endothelial
cells (12, 15). In preliminary experiments, we identified the optimal
concentrations of the cytokines to be 100 units/ml TNF- , 1 ng/ml
IL-1 , and 50 units/ml IFN- (data not shown). We found that
NOx and H2O2 accumulated in the culture
medium in a time-dependent fashion and that NOx and
H2O2 production was maximal in the presence of
TNF- and IFN- (Table I).
View this table:
[in this window]
[in a new window]
|
Table I
In vitro time course production of NO and H2O2 by
cytokine-activated HSE
Cytokines or vehicle (physiological saline) was added to 24-h cultured
HSE cells. Data represent the total amount of NOx and
H2O2 that accumulated in the medium during the
indicated time periods. During the 6-h period of incubation, the
percentage of HSE cell viability was 99-100% in all cases. Values are
means ± S.D. of five to six different experiments.
|
|
NO and H2O2 Levels during B16M Adhesion to
the HSE in Vitro--
In the second set of experiments, we used an
in vitro B16 melanoma-endothelial cell adhesion assay to
investigate NO and H2O2 production during the
process of tumor cell attachment to the HSE. In these experiments, the
combination of TNF- and IFN- was used as a potent activator of NO
and H2O2 generation by the HSE (Table I) and
also by the melanoma cells (16). For comparison, IL-1 was also used.
B16M cells obtained from cultures with low cellular density (LD cells,
which have high GSH content and high metastatic activity in
vivo) or from cultures with high cellular density (HD cells, which
have lower GSH content and metastatic activity) (25) were independently
co-cultured with HSE cells, and the results were compared (Table
II). In these experiments, before
addition to the HSE, GSH content in the B16M cells was 37 ± 6 nmol/106 LD cells and 10 ± 3 nmol/106 HD
cells (n = 5-6 in both cases). The percentage of tumor
cell adhesion to the HSE was not significantly different when both types of B16M cell subsets were compared (e.g. 47.6 ± 6.5% in the case of HD B16M cells, n = 7). To
calculate the percentage of NOx produced by the HSE during the
adhesion process, in parallel experiments, we used HSE cells
pre-cultured for 12 h in the presence of 1 mM
L-NAME, which blocks NO synthesis activity (42, 43) (under
these conditions, after washing with medium and culturing in the
absence of tumor cells, HSE cells do not produce detectable amounts of
NO or NO in the following 4 h).
Similar results were obtained when NOx produced by the HSE was calculated by subtracting NOx produced by co-cultured HSE and
B16M cells from NOx produced by cultured B16M cells alone (data
not shown). The percentage of H2O2 generated by
the HSE was calculated by subtracting H2O2
produced by co-cultured HSE and B16M cells from
H2O2 produced by cultured B16M cells alone (data not shown). Our data show that, during the adhesion process, most
of the NO and H2O2 were generated by the HSE
(Table II). Pre-culture of endothelial cells in the presence of
L-NAME did not alter the percentage of B16M cell adhesion
(data not shown) as compared with controls (see above).
View this table:
[in this window]
[in a new window]
|
Table II
In vitro NO and H2O2 production during B16M adhesion to
the HSE
Twenty-four-h cultured HSE cells (~2.5 × 105
cells/well) were co-cultured with B16M cells (~5.0 × 105 cells/well; pre-cultured for 12 h to low cellular
density for LD cells or for 72 h to high cellular density for HD
cells). Twenty min after B16M addition to the HSE, the plates were
washed as described under "Experimental Procedures." Taking into
account the percentage of tumor cell adhesion to the endothelial cells
(see "Results"), in these experiments, the ratio of tumor cells
adhering to the HSE cells was ~1:1. Measurements of NOx and
H2O2 accumulation (±cytokines) were restricted to
co-cultures in which all tumor cells adhered to the HSE. Cytokines
(concentrations were identical to those listed in the legend to Table
I) or vehicle (physiological saline) was added to the cultures when all
tumor cells present were attached to the HSE. Data represent the total
amount of NOx and H2O2 that accumulated in the
culture medium during a 3-h period. During this incubation period, both
HSE and B16M cells maintained a viability >95% (data not shown).
NOx and H2O2 values are expressed as
nmol/106 cells. NOx and H2O2 generated
by the HSE are expressed as % HSE. Values represent means ± S.D.
of five to six different experiments.
|
|
HSE-induced Tumor Cytotoxicity--
The specific NO- and/or
H2O2-induced tumor cytotoxicity during the
adhesion process was studied in co-cultures of HSE and B16M cells
(Table III). We used HSE cells isolated
from eNOS-deficient (eNOS / ) mice to abolish
eNOS-dependent NO production and L-NAME to
inhibit both inducible and endothelial NO synthase activities. Addition of exogenous catalase was used to eliminate
H2O2 released to the extracellular medium. LD
and HD B16M cell subsets where compared in the absence or presence of
TNF- and IFN- . As shown in Table III, HSE-induced tumor
cytotoxicity was significantly higher in B16M cells pre-cultured to
high density, a fact that is in agreement with our previous
observations (24, 25). In addition, we observed that a high rate of
NOx and H2O2 accumulation (as occurs in
the presence of inducing cytokines) correlated with an increasing percentage of nonviable tumor cells (Table III). Tumor cytotoxicity decreased significantly when B16M cells were co-cultured with eNOS / HSE cells, where only the rate
of NOx accumulation decreased (Table III). Moreover,
L-NAME treatment of eNOS+/+ HSE cells
completely abolished NOx accumulation and tumor cell death
without altering H2O2 accumulation (Table III). These facts indicate that H2O2 is not cytotoxic
by itself or that it requires additional factors, likely NO, to promote
irreversible tumor cell damage. When B16M cells where co-cultured with
eNOS+/+ HSE cells in the presence of exogenous catalase,
which decreases H2O2 accumulation to very low
levels (10% or less of control values), only in the case of HD B16M
cells was a significant decrease in the percentage of tumor
cytotoxicity observed (Table III).
View this table:
[in this window]
[in a new window]
|
Table III
NO- and H2O2-dependent cytotoxicity in B16M
cells attached to the HSE
eNOS-deficient mice were generated as described under "Experimental
Procedures." HSE cells isolated from wild-type, eNOS+/+, or
eNOS / mice were co-cultured with B16M cells as described in
legend to Table II. TNF- and IFN- (concentrations were identical
to those used in Table I) or vehicle (physiological saline) was added,
and determination of NOx and H2O2 accumulation
was restricted to co-cultures in which all tumor cells were attached to
HSE cells. In these experiments, 1 mM L-NAME and
103 units/ml catalase were used (see "Results"). Data
represent the total amount of NOx and H2O2 that
accumulated in the culture medium during the first 3 h of
incubation (where tumor cell viability was >95% in all cases; data
not shown). Tumor cytotoxicity (expressed as the % of tumor cells that
lost viability within the 4-6-h period of incubation, see
"Experimental Procedures") was determined after 6 h of
incubation. During the 6-h period of incubation, the percentage of HSE
cell viability was 99-100% in all cases. Data are means ± S.D.
of five to six different experiments. ND, not detectable.
|
|
To investigate whether these effects are tumor GSH content-related, we
used, in parallel experiments, LD B16M cells pre-cultured in the
presence of L-buthionine (RS)-sulfoximine (BSO;
a nontoxic and selective inhibitor of -glutamylcysteine synthetase,
the rate-limiting step in GSH synthesis) (44) and HD B16M cells pre-cultured in the presence of GSH ester (which rapidly enters the
cell and delivers free GSH) (25). GSH content in BSO-treated LD B16M
cells was not significantly different from that found in control HD
B16M cells, whereas GSH content in GSH ester-treated HD B16M cells was
not significantly different from that found in control LD B16M cells
(Table IV). HSE-induced tumor
cytotoxicity in BSO-treated LD B16M cells was similar to that found in
HD B16M cells, whereas HSE-induced tumor cytotoxicity in GSH
ester-treated HD B16M cells decreased to values similar to those found
in control LD B16M cells (Table IV). These facts indicate that GSH is
directly involved in the protection of B16M cells against HSE-induced
cytotoxicity. Nevertheless, which molecular mechanisms relevant to
metastatic activity are regulated by GSH, e.g. enzyme
activities or signaling molecules, is an important question that needs
further study.
View this table:
[in this window]
[in a new window]
|
Table IV
Role of GSH in preventing HSE-induced B16M cytotoxicity in vitro
HSE and B16M cells were cultured as described in the legend to Table
II. TNF- and IFN- (concentrations were identical to those used in
Table I) were present under all conditions and were added to
co-cultures as described in the legend to Table III. B16M cells were
pre-cultured in the absence or presence of BSO or GSH ester. GSH values
in LD B16M cells represent those found, in the absence or presence of
100 µM BSO (added to the culture at 0 h), 12 h
after plating. GSH values in HD B16M cells represent those found, in
the absence or presence of 1 mM GSH ester (added to the
culture at 71 h), 72 h after plating. Tumor cytotoxicity is
expressed as the % of tumor cells that lost viability within a 6-h
period of incubation. Data are means ± S.D. of five to six
different experiments.
|
|
Tumor Cytotoxicity of Nitrogen- and Oxygen-derived Reactive
Species--
The mechanisms by which NO and
H2O2 induce tumor cytotoxicity were further
investigated in experiments in which B16M cells were directly exposed
to NO and/or H2O2 at concentrations that reflect those found in co-cultures of HSE and B16M cells (see Table
II). As shown in Table V, NO displayed a
limited cytotoxicity (e.g. an ~18% increase in HD B16M
cells compared with basal medium-treated cells), whereas
H2O2 did not alter B16M cell viability as
compared with controls. However, when NO and
H2O2 were added together to the cultures, we
observed a dramatic increase in tumor cytotoxicity (e.g.
>70% in HD B16M cells). These results show that the NO-mediated loss
of tumor cell viability depends on both NO and
H2O2. Peroxynitrite also showed cytotoxic
effects, but they were lower compared with those found in the presence
of NO and H2O2 (Table V). Incubation of B16M
cells in the presence of NO and superoxide dismutase, which removes
O 2 anions and increases H2O2 levels,
caused more B16M cell toxicity than NO alone (Table V). Furthermore, we
used EGTA to remove metal ions present in the culture medium and found that, under these conditions, NO/H2O2-mediated
cytotoxicity was decreased to values similar to those found in the
presence of NO alone (Table V). Moreover, addition of NO,
H2O2, and FeCl3 to EGTA-pretreated
B16M cells again increased tumor cytotoxicity to values similar to
those induced by NO and H2O2. These results suggest, as previously proposed (45), a trace metal-catalyzed process
within a mechanism where different reactions may take place,
e.g. NO + H2O2, which generates
NO + ·OH + H+ via
a Fenton process; Fe(III) + NO + H2O2, which
generates Fe(II) + OONO + 2H+ (in the intact
cells, other reducing agents, e.g. ascorbate, may be also
utilized to reduce metals); ·OH + H2O2,
which generates ·OOH + H2O; or ·OOH + NO,
which generates OONO + H+. Chemical
mechanisms that can produce potent oxidants, such as ·OH and
OONO, could contribute to the observed
NO/H2O2-induced tumor cytotoxicity.
View this table:
[in this window]
[in a new window]
|
Table V
B16M cytotoxicity of nitrogen- and/or oxygen-derived reactive
species
B16M cells were cultured for 12 h to low cellular density
(LD cells) or for 72 h to high cellular density (HD cells). NO (10 µM), H2O2 (100 µM),
superoxide dismutase (SOD; 100 units/ml), OONO (10 µM), EGTA (0.5 mM), or ebselen (10 µM) was added at 12 or 72 h of culture.
FeCl3 (1 mM) was added 5 min after EGTA addition.
Tumor cytotoxicity (see "Experimental Procedures") is expressed as
the % of tumor cells that lost viability within a 1-h period of
incubation. Data are means ± S.D. of eight to nine different
experiments.
|
|
NO- and H2O2-induced Changes in the
Antioxidant Potential of Tumor Cells--
Under normal conditions,
cells utilize catalase and GSH peroxidase activities to maintain low
intracellular H2O2 levels. However, as
previously suggested in cell-free experiments (45), highly oxidant
radical species may cause alterations in
H2O2-catabolizing enzymes. In addition,
S-nitrosation of many enzymes and proteins has been
observed, and the chemical modification may affect activity (46).
Moreover, NO can form nitroso adducts with different thiols, such as
GSH and cysteine-containing proteins (47), and RSNO may also inactivate
enzyme activities (46). GSH, the most abundant cytosolic thiol, is used
in the GSH peroxidase-catalyzed reaction and easily reacts with NO,
forming GSNO, and thus may play a key role in regulating tumor cell
resistance to nitrosative and oxidative stress. We explored these
mechanisms by measuring GSH status, formation of RSNO, catalase
activity, and the GSH peroxidase/GSH reductase system activity in
cultured B16M cells exposed to NO and/or H2O2.
As shown in Table VI, NO and
H2O2 addition induced a decrease in GSH levels
and an increase in GSSG levels in the B16M cells, implying decreases in
the GSH redox status (GSH/GSSG ratio) to ~10 and 6% of controls in
LD and HD B16M cells, respectively. When comparing LD and HD B16M
cells, the different extent of GSH depletion is not surprising if one
takes into account that GSH synthesis is much more active in HD cells
(25). In addition, NO promoted an increase in RSNO formation, which was
higher in B16M cells with higher GSH content (LD cells) (Table VI).
Moreover, the increase in nitrosative and oxidative stress-related
molecular markers was associated with a significant decrease in
catalase activity in both B16M cell subsets, whereas the GSH
peroxidase/GSH reductase system (Table VI) or the total superoxide
dismutase (2.1 ± 0.3 units/106 LD cells and 1.5 ± 0.2 units/106 HD cells; n = 5) activity
remained unaffected. In agreement with these findings, we observed that
ebselen, a GSH peroxidase mimic (48), was able to prevent the increase
in NO toxicity induced by H2O2 (Table V). These
facts suggest that, during their interaction with the HSE, B16M cells
depend mainly on the GSH peroxidase/GSH reductase system to catabolize
H2O2 and thus to prevent cytotoxic damage
induced by highly oxidant radical species. Thus, the low GSH content
found in HD B16M cells may be the cause of their higher sensitivity to
nitrosative and oxidative attacks.
View this table:
[in this window]
[in a new window]
|
Table VI
Effect of NO and H2O2 on glutathione redox status,
formation of nitrosothiols, and the H2O2-catabolizing
enzyme activities in B16M cells
NO (10 µM) and/or H2O2 (100 µM) was added at 12 h (LD B16M cells) or 72 h
(HD B16M cells) of culture. Measurements were performed 1 h after
NO and/or H2O2 addition. Intracellular levels of GSH,
GSSG, and RSNO are expressed as nmol/106 cells. Catalase (CAT),
GSH peroxidase (GPx), and GSH reductase (GR) activities are expressed
as milliunits/106 cells. Data are means ± S.D. of five to
six different observations.
|
|
 |
DISCUSSION |
Intravascular oxidative stress elicited by leukocytes and
endothelial cells contributes to the elimination of circulating and
capillary-arrested cancer cells (49, 50). Indeed, direct in
vitro lysis of metastatic tumor cells by cytokine-activated murine
vascular endothelial cells has been shown (4). In agreement with this
are the findings that B16M cells pretreated with the lipophilic
antioxidant -tocopherol (vitamin E) in vitro increased their survival in the hepatic sinusoids (51), that an increase in B16M
cell GSH content upon hydroxyurea treatment also transiently increased
metastasis (52), that capillary survival decreased in GSH-depleted B16M
cells (24), and that B16M cells with high GSH content showed higher
metastatic activity in the liver than those with lower GSH content
(25). Nevertheless, how some metastatic cells survive their interaction
with endothelial cells is a mechanism that is poorly understood.
Despite lethal effects on metastatic cells, oxidative stress may
additionally create a pro-metastatic microenvironment at target organs
by increasing cell adhesion molecule expression in both endothelial
(53) and cancer (6) cells, activation of the early growth response-1
transcription factor gene (54), and activation of cancer and
endothelial cell metalloproteinases (55). In consequence, although the
antioxidant capacity of cancer cells may determine their intravascular
survival, surviving cells may benefit from oxidative stress-promoting
metastatic mechanisms.
By regulating vasodilatation, platelet aggregation, angiogenesis,
production of prostaglandins, or leukocyte proliferation or by
mediating tumor cytotoxicity (56), NO can affect tumor cell arrest in
capillaries and metastasis. NO reversibly binds to cytochrome
c oxidase and inhibits the respiration of tumor cells, an
effect that can be suppressed by GSH (32). By interacting with their
iron centers or forming RSNO, NO can affect the activity of
membrane-bound, cytosolic, and nuclear proteins, including the
N-methyl-D-aspartic acid receptor,
hemoglobin, and transcription factors such as nuclear factor- B and
SoxR; and in addition, by inducing S-nitrosylation of
caspases and tissue transglutaminase, NO may regulate the balance
between apoptosis and necrosis (57).
This study was undertaken to determine the role of NO and
H2O2 in the HSE-induced cytotoxic effect on
B16M cells during their adhesion process. Cytokine-mediated activation
of endothelial cells during the metastatic process is a mechanism that
must be expected to occur in vivo (see references cited in
the "Introduction"). Thus, comparative studies in the presence and
absence of cytokines appeared necessary. Our results reveal that
inhibition of cytokine-activated endothelial NO production abrogates
HSE-induced tumor cytotoxicity without altering endothelial
H2O2 production (Table III). However, NO-induced tumor cytotoxicity was significantly decreased by
catalase-mediated removal of extracellular H2O2
(Table III). Interestingly, previous observations showed that when NO
was added in vitro to a superoxide-generating system,
catalase inhibited the production of singlet oxygen, whereas superoxide
dismutase enhanced it (58). In addition, it was shown that
H2O2 enhanced the tumoricidal activity of NO in
rat hepatoma cells, although no evidence was found for an interplay of
NO with O 2 in cytotoxicity (21). We explored the chemical
mechanisms by which NO and H2O2 are cytotoxic
and found that a major part of the effect requires the presence of
trace metals capable of generating highly oxidant radicals, likely
·OH and OONO (see "Results" and Table V).
However, under physiological conditions, the intracellular
concentrations of free iron and H2O2 are kept
very low by iron-binding proteins and the catalase/GSH peroxidase
activities. Nevertheless, NO and O 2 can also release iron from
proteins (59). In addition, NO and OONO can increase
intracellular H2O2 by inhibiting the
mitochondrial respiratory chain (32, 60) or through the inhibition of
catalase (Table VI). Therefore, it is possible that NO may induce the
release of catalytic amounts of free iron and increase
H2O2 levels in the intact tumor cells.
Despite the fact that HSE-derived NO and H2O2
cause B16M cytotoxicity (Table III) and although findings in other cell
systems support this cooperative action (e.g. Refs. 20, 21,
45, and 61), others have suggested that NO protects against reactive oxygen species (62, 63). A plausible explanation for this apparent
paradox is that both NO and H2O2 can show very
different effects depending on their concentrations. Indeed, recent
experiments in isolated mitochondria showed that NO reversibly
inhibited permeability transition pore opening with an IC50
of 11 nM; however, at higher concentrations (>2
µM), NO accelerated pore opening (64). Identically, low
levels of H2O2 (3-15 µM) may
cause a significant mitogenic response in mammalian cells, whereas
higher concentrations (>100 µM) may cause growth arrest
and cell damage (65). Therefore, considering the amount of NO and
H2O2 released by the HSE during the process of
cancer cell adhesion (Table II), tumor cytotoxicity may be expected, as
it indeed occurs (Table III).
Catalase activity was much lower in the presence of
NO/H2O2 than in the presence of NO. This
suggests the involvement of NO- and
H2O2-derived radical species. In fact, we
observed that OONO (10 µM) induced a
decrease in catalase activity (data not shown) similar to that induced
by NO and H2O2 (Table VI). In consequence, since no inhibition of the GSH peroxidase/GSH reductase system was
induced by NO and/or H2O2, B16M cells must rely
on this system to metabolize H2O2 and thereby
to prevent lethal toxicity. This is in agreement with the resistance to
macrophage-induced oxidative stress shown by tumor cells with high GSH
peroxidase activity, a fact that has no correlation with catalase
activity (66).
NO forms RSNO (Table VI) with different thiols, such as GSH, which
decreases the levels of free NO and thereby its biological activity.
GSNO, a slow releaser of NO, may also inhibit the respiration of tumor
cell mitochondria, but its effect is much lower than that of NO (32).
Nevertheless, NO-induced RSNO formation was not increased by
H2O2 (Table VI), which suggests that RSNO
formation is not required in the mechanism of NO- and
H2O2-induced cooperative tumor cytotoxicity
(see Tables III and IV). In addition, our results are also in agreement
with previous reports showing that depletion of cellular GSH reduces
the viability of cells exposed to NO (67). Indeed, GSH is implicated in
the regulation of the mitochondrion-based mechanisms that lead to cell
death (68). In conclusion, our results show that NO and
H2O2 are critical factors involved in the
tumoricidal activity of the HSE toward potentially metastatic cells.
The fact that B16M cells with high GSH content (LD cells) are much less
susceptible to NO- and H2O2-induced toxicity
(see "Results") establishes a close relationship between
intracellular GSH levels and cancer resistance against oxidative and
nitrosative stress within a metastatic microenvironment. The
biochemical mechanisms described in this report may explain, at least
in part, how some cancer cells survive during their interaction with
the endothelium and possibly with other cells such as macrophages and
intravascular granulocytes.
 |
FOOTNOTES |
*
This work was supported in part by Grants SAF99-112 and
1FD97-548 from the Comisión Interministerial de Ciencia y
Tecnología (Spain).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by a fellowship from the Generalitat Valenciana.
¶
Supported by a Carmen and Severo Ochoa fellowship from the
Ayuntamiento de Valencia.
Supported by fellowships from the Ministerio de Ciencia y
Tecnología (Spain).

To whom correspondence should be addressed: Dept. de
Fisiología, Facultad de Medicina y Odontología, Av.
Blasco Ibañez 17, 46010 Valencia, Spain. Tel.: 34-963864-646;
Fax: 34-963864-642; E-mail: jose.m.estrela@uv.es.
Published, JBC Papers in Press, April 19, 2001, DOI 10.1074/jbc.M101148200
 |
ABBREVIATIONS |
The abbreviations used are:
B16M, B16 melanoma;
HSE, hepatic sinusoidal endothelium;
IL-1, interleukin-1;
TNF- , tumor necrosis factor- ;
eNOS, endothelial nitric-oxide synthetase;
L-NAME, NG-nitro-L-arginine methyl
ester;
LD cells, cells cultured to low density;
HD cells, cells
cultured to high density;
BCECF-AM, 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester;
IFN- , interferon- ;
NOx, nitrite plus nitrate;
RSNO, S-nitrosothiols;
GSNO, S-nitrosoglutathione;
DTPA, diethylenetriaminepentaacetic acid;
PBS, phosphate-buffered
saline;
BSO, L-buthionine
(RS)-sulfoximine.
 |
REFERENCES |
| 1.
|
Fidler, I. J.
(1990)
Cancer Res.
50,
6130-6138
|
| 2.
|
Fidler, I. J.
(1970)
J. Natl. Cancer Inst.
46,
773-783
|
| 3.
|
Weiss, L.
(1990)
Adv. Cancer Res.
54,
159-211
|
| 4.
|
Li, L.,
Nicolson, G. L.,
and Fidler, I. J.
(1991)
Cancer Res.
51,
245-254
|
| 5.
|
Bayón, L. G.,
Izquierdo, M. A.,
Sirovich, I.,
Van Rooijen, N.,
Beelen, R. H. J.,
and Meijer, S.
(1996)
Hepatology
23,
1224-1231
|
| 6.
|
Anasagasti, M. J.,
Alvarez, A.,
Martin, J. J.,
Mendoza, L.,
and Vidal- Vanaclocha, F.
(1997)
Hepatology
25,
840-846
|
| 7.
|
Rice, G. E.,
Gimbrone, M. A.,
and Bevilacqua, M. P.
(1988)
Am. J. Pathol.
133,
204-210
|
| 8.
|
Giavazzi, R.,
Garofalo, A.,
Bani, M. R.,
Abbate, M.,
Gheezzi, P.,
Boraschi, D.,
Mantovani, A.,
and Dejana, E.
(1990)
Cancer Res.
50,
4771-4775
|
| 9.
|
Orosz, P.,
Echtenacher, B.,
Falk, W.,
Ruschoff, J.,
Weber, D.,
and Mannel, D. N.
(1993)
J. Exp. Med.
177,
1391-1398
|
| 10.
|
Matsubara, T.,
and Ziff, M.
(1986)
J. Immunol.
137,
3295-3298
|
| 11.
|
McCloskey, T. W.,
Todaro, J. A.,
and Laskin, D. L.
(1992)
Hepatology
16,
191-203
|
| 12.
|
Anasagasti, M. J.,
Alvarez, A.,
Avivi, C.,
and Vidal-Vanaclocha, F.
(1996)
J. Cell. Physiol.
167,
314-323
|
| 13.
|
Burdon, R. H.
(1995)
Free Radic. Biol. Med.
18,
775-794
|
| 14.
|
Marui, N.,
Offermann, M. K.,
Swerlick, R.,
Kunsch, C.,
Rosen, C. A.,
Ahmad, M.,
Alexander, R. W.,
and Medford, R. M.
(1993)
J. Clin. Invest.
92,
1866-1874
|
| 15.
|
Li, L.,
Kilbourn, R. G.,
Adams, J.,
and Fidler, I. J.
(1991)
Cancer Res.
51,
2531-2535
|
| 16.
|
Dong, Z.,
Staroselsky, A. H.,
Qi, X.,
Xie, K.,
and Fidler, I. J.
(1994)
Cancer Res.
54,
789-793
|
| 17.
|
Wang, H. H.,
McIntosh, A. R.,
Hasinoff, B. B.,
Rector, E. S.,
Ahmed, N.,
Nance, D. M.,
and Orr, W. F.
(2000)
Cancer Res.
60,
5862-5869
|
| 18.
|
Hibbs, J. B., Jr.,
Taintor, R. R.,
and Vavrin, Z.
(1988)
Biochem. Biophys. Res. Commun.
157,
87-94
|
| 19.
|
Koppenol, W. H.,
Moreno, J. J.,
Pryor, W. A.,
Ischiropolous, H.,
and Beckman, J. S.
(1992)
Chem. Res. Toxicol.
5,
834-842
|
| 20.
|
Pacelli, R.,
Wink, D. A.,
Cook, J. A.,
Krishna, M. C.,
DeGraff, W.,
Friedman, N.,
Tsokos, M.,
Samuni, A.,
and Mitchell, J. B.
(1995)
J. Exp. Med.
182,
1469-1479
|
| 21.
|
Ioannidis, I.,
and De Groot, H.
(1993)
Biochem. J.
296,
341-345
|
| 22.
|
Jessup, J. M.,
Battle, P.,
Waller, H.,
Edmiston, K. H.,
Stolz, D. B.,
Watkins, S. C.,
Locker, J.,
and Skena, K.
(1999)
Cancer Res.
59,
1825-1829
|
| 23.
|
Sies, H.
(1999)
Free Radic. Biol. Med.
9/10,
916-921
|
| 24.
|
Anasagasti, M. J.,
Martin, J. J.,
Mendoza, L.,
Obrador, E.,
Estrela, J. M.,
McCuskey, R. S.,
and Vidal-Vanaclocha, F.
(1998)
Hepatology
27,
1249-1256
|
| 25.
|
Carretero, J.,
Obrador, E.,
Anasagasti, M. J.,
Martin, J. J.,
Vidal-Vanaclocha, F.,
and Estrela, J. M.
(1999)
Clin. Exp. Metastasis
17,
567-574
|
| 26.
|
Vidal-Vanaclocha, F.,
Rocha, M.,
Asumendi, A.,
and Barbera-Guillem, E.
(1993)
Hepatology
18,
328-339
|
| 27.
|
Bergmeyer, H. U.,
and Bernt, E.
(1985)
in
Methods of Emzymatic Analyses
(Bergmeyer, H. U., ed), Vol. 2
, pp. 574-579, Academic Press, New York
|
| 28.
|
Ruch, W.,
Cooper, P. H.,
and Baggiolini, M.
(1983)
J. Immunol. Methods
63,
347-357
|
| 29.
|
Braman, R. S.,
and Hendrix, S. A.
(1989)
Anal. Chem.
61,
2715-2718
|
| 30.
|
Akerboom, T. P. M.,
and Sies, H.
(1981)
Methods Enzymol.
77,
373-382
|
| 31.
|
Asensi, M.,
Sastre, J.,
Pallardó, F. V.,
García de la Asunción, J.,
Estrela, J. M.,
and Viña, J.
(1994)
Anal. Biochem.
217,
323-328
|
| 32.
|
Nishikawa, M.,
Sato, E. F.,
Kashiba, M.,
Kuroki, T.,
Utsumi, K.,
and Inoue, M.
(1998)
Hepatology
27,
422-426
|
| 33.
|
Hart, T. W.
(1985)
Tetrahedron Lett.
26,
2013-2016
|
| 34.
|
Martensson, J.,
and Meister, A.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
471-475
|
| 35.
|
Clancy, R. M.,
Miyazaki, Y.,
and Cannon, B. J.
(1990)
Anal. Biochem.
191,
138-143
|
| 36.
|
Ahmed, A.,
Dunk, C.,
Kniss, D.,
and Wilkes, M.
(1997)
Lab. Invest.
76,
779-791
|
| 37.
|
Uppu, R. M.,
and Pryor, W. A.
(1996)
Methods Enzymol.
269,
322-329
|
| 38.
|
Flohé, L.,
and Gunzler, W. A.
(1984)
Methods Enzymol.
105,
114-121
|
| 39.
|
Flohé, L.,
and Otting, F.
(1984)
Methods Enzymol.
105,
93-104
|
| 40.
|
Aebi, H.
(1984)
Methods Enzymol.
105,
121-126
|
| 41.
|
Shesely, E. G.,
Maeda, N.,
Kim, H. S.,
Desai, K. M.,
Krege, J. H.,
Laumback, V. E.,
Sherman, P. A.,
Sessa, W. C.,
and Smithies, O.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13176-13181
|
| 42.
|
Rees, D. D.,
Palmer, R. M.,
Schulz, R.,
Hodson, H. F.,
and Moncada, S.
(1990)
Br. J. Pharmacol.
101,
746-752
|
| 43.
|
Buttery, L. D.,
Springall, D. R.,
Andrade, S. P.,
Riveros-Moreno, V.,
Hart, I.,
Piper, P. J.,
and Polak, J. M.
(1993)
J. Pathol.
171,
311-319
|
| 44.
|
Meister, A.
(1991)
Pharmacol. Ther.
51,
155-194
|
| 45.
|
Farias-Eisner, R.,
Chaudhuri, G.,
Aeberhard, E.,
and Fukuto, J. M.
(1996)
J. Biol. Chem.
271,
6144-6151
|
| 46.
|
Hogg, N.
(2000)
Free Radic. Biol. Med.
28,
1478-1486
|
| 47.
|
Kharitonov, V. G.,
Sunquist, A. R.,
and Sharma, V. S.
(1995)
J. Biol. Chem.
270,
28158-28164
|
| 48.
|
Sies, H.,
and Arteel, G. E.
(2000)
Free Radic. Biol. Med.
28,
1451-1455
|
| 49.
|
Glaves, D.
(1986)
Invasion Metastasis
6,
101-111
|
| 50.
|
Weiss, L.,
Orr, F. W.,
and Honn, K. V.
(1988)
FASEB J.
2,
12-21
|
| 51.
|
Albertsson, P. A.,
Nannmark, U.,
and Johansson, B. R.
(1995)
Clin. Exp. Metastasis
13,
269-276
|
| 52.
|
Eskenazi, A. E.,
Pinkas, J.,
Whitin, J. C.,
Argüello, F.,
Cohen, H. J.,
and Frantz, C. N.
(1993)
J. Natl. Cancer Inst.
85,
711-721
|
| 53.
|
Sellak, H.,
Franzini, E.,
Hakim, J.,
and Pasquier, C.
(1994)
Blood
83,
2669-2677
|
| 54.
|
Datta, R.,
Hallahan, D. E.,
Kharbanda, S. M.,
Rubin, E.,
Sherman, M. L.,
Huberman, E.,
Weichselbaum, R. R.,
and Kufe, D. W.
(1992)
Biochemistry
31,
8300-8306
|
| 55.
|
Lafrenie, R.,
Saughnessy, S. G.,
and Orr, F. W.
(1992)
Cancer Metastasis Rev.
11,
377-388
|
| 56.
|
Wink, D. A.,
Vodovotz, Y.,
Laval, J.,
Laval, F.,
Dewhirst, M. W.,
and Mitchell, J. B.
(1998)
Carcinogenesis
19,
711-721
|
| 57.
|
Mellino, G.,
Bernassola, F.,
Knight, R. A.,
Corasaniti, M. T.,
and Finazzi-Agrò, G. N. A.
(1997)
Nature
388,
432-433
|
| 58.
|
Noronha-Dutra, A. A.,
Epperlein, M. M.,
and Woolf, N.
(1993)
FEBS Lett.
321,
59-62
|
| 59.
|
Fridovich, I.
(1995)
Annu. Rev. Biochem.
64,
97-112
|
| 60.
|
Sharpe, M. A.,
and Cooper, C. E.
(1998)
J. Biol. Chem.
273,
30961-30972
|
| 61.
|
Chiang, K. T.,
Switzer, C. H.,
Akali, K. O.,
and Fukuto, J. M.
(2000)
Toxicol. Appl. Pharmacol.
167,
30-36
|
| 62.
|
Wink, D. A.,
Hanbaur, I.,
Krishna, M. C.,
DeGraff, W.,
Gamson, J.,
and Mitchell, J. B.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
9813-9817
|
| 63.
|
Gupta, M. P.,
Evanoff, V.,
and Hart, C. M.
(1997)
Am. J. Physiol.
272,
L1133-L1141
|
| 64.
|
Brookes, P. S.,
Padilla Salinas, E.,
Darley-Usmar, K.,
Eiserich, J. P.,
Freeman, B. A.,
Darley-Usmar, V. M.,
and Anderson, P. G.
(2000)
J. Biol. Chem.
275,
20474-20479
|
| 65.
|
Davies, K. J. A.
(1999)
Int. Union Biochem. Mol. Biol. Life
48,
41-47
|
| 66.
|
Arrick, B. A.,
and Nathan, C. F.
(1984)
Cancer Res.
44,
4224-4232
|
| 67.
|
Walker, M. W.,
Kinter, M. T.,
Roberts, R. J.,
and Spitz, D. R.
(1995)
Pediatr. Res.
37,
41-49
|
| 68.
|
Kroemer, G.,
and Reed, J. C.
(2000)
Nat. Med.
6,
513-519
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Mena, M. Benlloch, A. Ortega, J. Carretero, E. Obrador, M. Asensi, I. Petschen, B. D. Brown, and J. M. Estrela
Bcl-2 and Glutathione Depletion Sensitizes B16 Melanoma to Combination Therapy and Eliminates Metastatic Disease
Clin. Cancer Res.,
May 1, 2007;
13(9):
2658 - 2666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ferrer, M. Asensi, S. Priego, M. Benlloch, S. Mena, A. Ortega, E. Obrador, J. M. Esteve, and J. M. Estrela
Nitric Oxide Mediates Natural Polyphenol-induced Bcl-2 Down-regulation and Activation of Cell Death in Metastatic B16 Melanoma
J. Biol. Chem.,
February 2, 2007;
282(5):
2880 - 2890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Benlloch, S. Mena, P. Ferrer, E. Obrador, M. Asensi, J. A. Pellicer, J. Carretero, A. Ortega, and J. M. Estrela
Bcl-2 and Mn-SOD Antisense Oligodeoxynucleotides and a Glutamine-enriched Diet Facilitate Elimination of Highly Resistant B16 Melanoma Cells by Tumor Necrosis Factor-{alpha} and Chemotherapy
J. Biol. Chem.,
January 6, 2006;
281(1):
69 - 79.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Benlloch, A. Ortega, P. Ferrer, R. Segarra, E. Obrador, M. Asensi, J. Carretero, and J. M. Estrela
Acceleration of Glutathione Efflux and Inhibition of {gamma}-Glutamyltranspeptidase Sensitize Metastatic B16 Melanoma Cells to Endothelium-induced Cytotoxicity
J. Biol. Chem.,
February 25, 2005;
280(8):
6950 - 6959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mocellin, M. Provenzano, C. R. Rossi, P. Pilati, R. Scalerta, M. Lise, and D. Nitti
Induction of Endothelial Nitric Oxide Synthase Expression by Melanoma Sensitizes Endothelial Cells to Tumor Necrosis Factor-Driven Cytotoxicity
Clin. Cancer Res.,
October 15, 2004;
10(20):
6879 - 6886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Laguinge, S. Lin, R. N. Samara, A. N. Salesiotis, and J. M. Jessup
Nitrosative Stress in Rotated Three-Dimensional Colorectal Carcinoma Cell Cultures Induces Microtubule Depolymerization and Apoptosis
Cancer Res.,
April 15, 2004;
64(8):
2643 - 2648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ortega, P. Ferrer, J. Carretero, E. Obrador, M. Asensi, J. A. Pellicer, and J. M. Estrela
Down-regulation of Glutathione and Bcl-2 Synthesis in Mouse B16 Melanoma Cells Avoids Their Survival during Interaction with the Vascular Endothelium
J. Biol. Chem.,
October 10, 2003;
278(41):
39591 - 39599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Ortega, J. Carretero, E. Obrador, J. Gambini, M. Asensi, V. Rodilla, and J. M. Estrela
Tumor Cytotoxicity by Endothelial Cells. IMPAIRMENT OF THE MITOCHONDRIAL SYSTEM FOR GLUTATHIONE UPTAKE IN MOUSE B16 MELANOMA CELLS THAT SURVIVE AFTER IN VITRO INTERACTION WITH THE HEPATIC SINUSOIDAL ENDOTHELIUM
J. Biol. Chem.,
April 11, 2003;
278(16):
13888 - 13897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Qiu, F.W. Orr, D. Jensen, H. H. Wang, A. R. McIntosh, B. B. Hasinoff, D. M. Nance, S. Pylypas, K. Qi, C. Song, et al.
Arrest of B16 Melanoma Cells in the Mouse Pulmonary Microcirculation Induces Endothelial Nitric Oxide Synthase-Dependent Nitric Oxide Release that Is Cytotoxic to the Tumor Cells
Am. J. Pathol.,
February 1, 2003;
162(2):
403 - 412.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|